People · Operator
Named in public records as an officer, director or promoter · active 2012–2016 · Healthtech, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Patient Home Monitoring Corp. | — | Healthtech | Series B | $72.5M | $116.9M | 2014 |
| Sancilio & Company, Inc. | — | Pharmaceuticals | Series B | $22.3M | $680.1M | 2012 |
Andrew Folmer at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Andrew Folmer on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Patrick Gray | 1 | 10 |
| Dennis Langer | 1 | 9 |
| NITIN KAUSHAL | 1 | 8 |
| David Hayes | 1 | 7 |
| MIKE MOORE | 1 | 4 |
| Frederick Sancilio | 1 | 4 |
| DAVID COSTINE | 1 | 3 |
| Roderick Jackson | 1 | 3 |
| D. Eugene Ewing | 1 | 3 |
| ROGER GREENE | 1 | 3 |
| CASEY HOYT | 1 | 2 |
| Alan Dunton | 1 | 2 |
| MICHAEL DALSIN | 1 | 2 |
| Mark Greenberg | 1 | 2 |
| CHRISTOPHER OVERALL | 1 | 1 |
| ASA STAFFORD | 1 | 1 |
| JESS CUTHBERT | 1 | 1 |
| Stephan Porter | 1 | 1 |
| Stephen Porter | 1 | 1 |
| Daren Graham | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.